Diabetes Insipidus: Diagnostic Criteria, Workup, and Management

Definition

• Goldman-Cecil Medicine, p. 2418

Classification

• Henry's Clinical Diagnosis and Management by Laboratory Methods, p. 737

Diagnostic Criteria

Clinical Presentation

• Polyuria (>3 L/day, up to 15-20 L/day in severe cases)
• Polydipsia (compensatory; driven by hypertonicity if thirst is intact)
• No hyperglycemia, no glycosuria (distinguishes from diabetes mellitus)
• If the thirst mechanism is impaired: rapid dehydration and hypernatremia

Initial Biochemical Screen

• Plasma osmolality elevated (>295 mOsm/kg; normal 280-295) - or inappropriately normal despite ongoing polyuria
• Serum sodium elevated or high-normal
• Urine osmolality inappropriately low (<300 mOsm/kg, often <100)
• Urine specific gravity <1.005
• Rule out glycosuria, hypercalcemia, hypokalemia (common causes of acquired nephrogenic DI)

Diagnostic Workup

Step 1: Confirm Water Diuresis vs. Solute Diuresis

• Uosm <100 mOsm/kg → water diuresis: DI (central or nephrogenic) or psychogenic polydipsia
• Uosm 100-300 mOsm/kg → mixed or partial DI; also consider CKD
• Uosm >300 mOsm/kg → solute diuresis (hyperglycemia, post-obstructive, high solute intake) - proceed with 24-hour urine collection

Step 2: Water Deprivation Test

1. For mild polyuria: withhold fluids from 10 PM onward. For severe polyuria (8-10 L/day): begin in the morning under close observation.
2. Baseline: urine volume (Uvol), urine osmolality (Uosm), plasma osmolality (Posm), serum Na, weight, BP and pulse (sitting and standing).
3. Collect urine and plasma hourly for Uvol, Uosm, Posm. Monitor weight, BP, pulse.
4. Stop when:
   • Uosm plateaus (hourly increase <30 mOsm/kg for 3 consecutive hours), OR
   • Body weight falls by 3-5%, OR
   • Systolic BP drops >20 mmHg
5. Administer 1 µg desmopressin IV or IM (or 5 µg AVP SC). Measure Uosm and urine output at 30, 60, and 120 minutes post-injection. Use the highest Uosm to evaluate response.

• Henry's Clinical Diagnosis, pp. 745-756

Step 3: Interpret Results

Step 4: Copeptin Testing (Modern Approach)

• Baseline copeptin >21.4 pmol/L (without prior thirsting): diagnostic of nephrogenic DI
• Copeptin ≤4.9 pmol/L after hypertonic saline infusion test: central DI (complete or partial)
• Copeptin >4.9 pmol/L after stimulation: primary polydipsia
• Combined with hypertonic infusion test: diagnostic accuracy 97% vs. ~80% for water deprivation test alone

• Henry's Clinical Diagnosis, pp. 787-789; Tietz Textbook of Laboratory Medicine, 7th Ed.

Step 5: Localize the Cause

• MRI brain/pituitary with gadolinium: look for absence of the posterior pituitary "bright spot" on T1, thickened pituitary stalk, hypothalamic mass
• If no obvious cause: check CSF (tumor cells, ACE level for neurosarcoidosis, β-HCG for germinoma)
• Genetic testing if family history suggests inherited mutation (vasopressin or AVP receptor gene)
• Important: Spontaneous central DI should not be labeled idiopathic until at least 4 years of follow-up with annual CT or MRI to exclude occult tumor or infiltrative process

• Check for causative medications: lithium, demeclocycline, amphotericin, cidofovir, foscarnet
• Check electrolytes: hypokalemia, hypercalcemia
• Genetic testing: AVPR2 mutations (X-linked, >90% of congenital cases), AQP2 mutations (<10%)
• Renal biopsy rarely needed
• Goldman-Cecil Medicine, pp. 2174-2320

Management

Central DI

• Katzung's Basic and Clinical Pharmacology, 16th Ed., p. 493; Goldman-Cecil Medicine

Nephrogenic DI

1. Remove or treat the underlying cause (stop lithium if possible, correct hypercalcemia, correct hypokalemia)
2. Low-sodium diet - reduces osmotic load and urine volume
3. Thiazide diuretics (e.g., hydrochlorothiazide) - paradoxically reduce urine volume by inducing mild volume depletion, which increases proximal tubular reabsorption and reduces water delivery to the collecting duct
4. Amiloride - especially useful in lithium-induced DI (blocks lithium entry into collecting duct cells via ENaC)
5. NSAIDs (e.g., indomethacin) - inhibit prostaglandin synthesis, which enhances ADH action; used in combination with thiazides in refractory cases

• Guyton and Hall Medical Physiology, p. 380; Goldman-Cecil Medicine

Primary Polydipsia

• Restrict fluid intake
• Treat underlying psychiatric condition if psychogenic
• Do not give desmopressin - this will cause severe hyponatremia
• All patients should have MRI of the brain before concluding the cause is idiopathic or psychiatric

Summary Table

Sources: Goldman-Cecil Medicine, Guyton & Hall Medical Physiology, Henry's Clinical Diagnosis and Management by Laboratory Methods, Tietz Textbook of Laboratory Medicine (7th Ed.), Katzung's Basic and Clinical Pharmacology (16th Ed.)

Harrison's vs. Other Textbooks: Are All the Tests Relevant?

The Tests Mentioned Across Textbooks and Their Status

1. Water Deprivation Test (Indirect AVP Test)

• Still relevant, but no longer the gold standard.
• Harrison's explicitly states: "The indirect water deprivation test was the gold standard for differential diagnosis for many years... the published criteria for interpretation were based on post hoc data from a small number of patients with an overall diagnostic accuracy of 70% and only 41% for patients with primary polydipsia."
• So it works, but is wrong in 30-60% of the hardest cases (partial DI vs. primary polydipsia). It is still useful when copeptin assays are unavailable.

2. Hypertonic Saline Infusion + Copeptin Measurement

• The new preferred gold standard per Harrison's 22nd edition.
• Raise plasma sodium to ≥150 mmol/L via hypertonic saline infusion, then measure copeptin:
  • Stimulated copeptin >4.9 pmol/L → Primary polydipsia
  • Stimulated copeptin ≤4.9 pmol/L → Central (AVP deficiency)
• Diagnostic accuracy: 96.5% vs. 70% for the water deprivation test
• Requires close monitoring of sodium levels during the infusion

3. Baseline Copeptin (No Prior Thirsting)

• Copeptin >21.4 pmol/L without water deprivation = diagnostic of nephrogenic DI (complete or partial)
• This alone can rule in nephrogenic DI immediately, skipping all further tests

4. Arginine Stimulation + Copeptin

• Harrison's references this as an emerging alternative to hypertonic saline
• Slightly lower diagnostic accuracy than hypertonic saline-stimulated copeptin
• Useful where hypertonic saline is not tolerated

5. Desmopressin Test (Post-Deprivation or Standalone)

• Administer 2 µg desmopressin SC, then recheck urine osmolality
• If urine Uosm increases >50%: central DI
• If <50% (or <9-10%): nephrogenic DI
• Harrison's uses this as a second-line clarifying step within the water deprivation pathway (for Uosm 300-800 mOsm/kg after deprivation)
• Also useful as a quick bedside screen: if serum Na is already >147 mmol/L, desmopressin test alone can differentiate central from nephrogenic DI without needing the full water deprivation protocol

6. Direct Plasma AVP Measurement

• Harrison's notes this was proposed but is not in routine clinical use because of technical assay limitations
• Copeptin has replaced it as the AVP surrogate

Harrison's Unified Diagnostic Algorithm (2025)

1. Confirm polyuria (>40-50 mL/kg/24 h) + urine osmolality <800 mOsm/kg
2. Measure serum sodium:
   • Na <135: Primary polydipsia
   • Na >147: Central or nephrogenic DI → give desmopressin to differentiate
   • Na 136-146 (most patients): need further testing
3. For normal Na, use two parallel pathways:
   • Baseline copeptin: if >21.4 pmol/L → nephrogenic DI confirmed. If <21.4 pmol/L → proceed to hypertonic saline test
   • Water deprivation test: still an option where copeptin is unavailable, but inferior
4. Hypertonic saline-stimulated copeptin at Na ≥150:

   • 4.9 → Primary polydipsia

   • ≤4.9 → Central DI

Practical Takeaway